MAPT and Alzheimer disease: In most cases, decreasing protein O-GlcNAcylation through OGT knock-down or by mimicking impaired glucose metabolism and uptake as in AD brain leads to increased site-specific phosphorylation of Tau (Liu et al., 2004, 2009).